Stay updated on High-Dose Eteplirsen in DMD Clinical Trial
Sign up to get notified when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.

Latest updates to the High-Dose Eteplirsen in DMD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAn NIH-wide notice about changing terminology appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study record still displays a 403 Forbidden error.SummaryDifference1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the expected content with an access-denied message and a Home link.SummaryDifference17%

- Check44 days agoChange DetectedUpdated page revision from v3.6.6 to v3.7.0, signaling a new version of the ClinicalTrials.gov study page. This metadata update does not affect the study details or content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a minor platform release.SummaryDifference0.0%

- Check65 days agoChange DetectedThe study record now includes a funding source entry for 2018 (U.S. NIH Grant/Contract), clarifying NIH support for the trial.SummaryDifference0.0%

Stay in the know with updates to High-Dose Eteplirsen in DMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.